FDA Inspection 1324668 — Sun Young Rha, M.D., Ph.D.
The FDA completed an inspection of Sun Young Rha, M.D., Ph.D. on June 12, 2026 in Seodaemun. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seodaemun (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)